Frontlight ResearchEarly access
Trial site
Abramson Cancer Center at Pennsylvania Hospital
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Sarcoma5 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- HIV1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- AIDS Malignancy Consortium2 trials
- BioAtla, Inc.1 trial
- Boehringer Ingelheim1 trial
- Inhibrx Biosciences, Inc1 trial
- Washington University School of Medicine1 trial
Running trials
Active, not recruiting
Active, not recruiting
Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026